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Abstract
Background: Our aim was to characterize clinical properties and laboratory parameters in patients with or without
cerebrospinal fluid (CSF) findings suggestive of central nervous system (CNS) involvement, and especially those
who developed serious CNS complications during acute nephropathia epidemica (NE) caused by Puumala
hantavirus (PUUV) infection.
Methods: A prospective cohort of 40 patients with acute NE and no signs of major CNS complications was
analyzed. In addition, 8 patients with major CNS complications associated with NE were characterized. We collected
data of CNS symptoms, CSF analysis, brain magnetic resonance imaging (MRI) results, electroencephalography
(EEG) recordings, kidney function, and a number of laboratory parameters. Selected patients were evaluated by an
ophthalmologist.
Results: Patients with a positive CSF PUUV IgM finding or major CNS complications were more often males (p <
0.05) and they had higher plasma creatinine values (p < 0.001) compared to those with negative CSF PUUV IgM.
The degree of tissue edema did not explain the CSF findings. Patients with major CNS complications were younger
than those with negative CSF PUUV IgM finding (52.9 vs. 38.5 years, p < 0.05). Some patients developed
permanent neurological and ophthalmological impairments.
Conclusions: CNS and ocular involvement during and after acute NE can cause permanent damage and these
symptoms seem to be attributable to true infection of the CNS rather than increased tissue permeability. The
possibility of this condition should be borne in mind especially in young male patients.
Keywords: hantavirus, encephalitis, hypopituitarism
Background
Puumala hantavirus (PUUV) causes a hemorrhagic fever
with renal syndrome (HFRS) also called Nephropathia
epidemica (NE). Although the condition is endemic in
Northern Europe, an increasing number of cases has
been reported throughout Europe, possibly due to cli-
mate change [1-3]. The virus is carried by the bank vole
(Myodes glareolus); human infection is acquired by inha-
lation of the virus from aerosolized excreta [1]. After an
incubation period of two to four weeks, the patient
develops symptoms, i.e. fever, headache, abdominal pain,
nausea, diarrhoea, renal insufficiency, and acute myopia
[1].
Many patients with acute NE display signs of central
nervous system (CNS) involvement [4-7] and evidence
of PUUV infection in the CNS has been provided [8,9].
Pituitary hemorrhage as a potential complication of NE
has been documented [7,8]. Headache, insomnia, ver-
tigo, nausea, nuchal rigidity, confusion, generalized sei-
zures, acute disseminated encephalomyelitis have been
reported and patients with meningoencephalitis after
* Correspondence: timo.hautala@oulu.fi
1Department of Internal Medicine, Oulu University Hospital, Oulu, Finland
Full list of author information is available at the end of the article
Hautala et al. BMC Infectious Diseases 2011, 11:217
http://www.biomedcentral.com/1471-2334/11/217
© 2011 Hautala et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.exposure to PUUV have been described [5,6,10-13]. In
general, however, hantaviruses may not have been
recognized as a typical causative agent of viral
encephalitis.
In this study, we characterized the clinical properties
of patients with encephalitis or significant CNS injury
caused by acute PUUV infection. We also compared the
clinical properties of NE patients with positive CSF
PUUV IgM finding to those negative for CSF PUUV
IgM. Our intention was to identify patient populations
that might be at elevated risk of developing significant
CNS illness associated with acute NE. In addition, our
aim was to analyze the clinical findings in order to
search for an explanation for the CNS involvement.
Methods
Study design
The patients of this study were partly recruited from
those hospitalized for acute NE in the Oulu University
Hospital in Northern Finland during September 2005 to
February 2008 and the patient population in full has
been described in detail elsewhere [7]. For the current
study, the data were collected from the 40 patients with-
out major CNS complications and from whom cere-
brospinal fluid (CSF) PUUV IgM analysis was available.
In addition, 8 patients who had been treated and identi-
fied to have suffered major CNS complications caused
by acute NE at Oulu University Hospital were included
to the study. Their hospital records and clinical findings
were scrutinized. These patients included three pre-
viously published cases (patients 6-8 in Tables 1 and 2)
who suffered severe CNS damage caused by PUUV [8].
The follow-up of each patient was organized individually
based on their symptoms.
We compared the clinical presentation of acute NE
without major CNS complications between the patients
with CSF PUUV IgM-negative cases (21 patients) to
those with CSF PUUV IgM-positive findings (19
patients) as well as with the patients who suffered major
CNS complications (8 patients). The study protocol was
explained to each patient and they had the right to
refuse or withdraw from the study according to the Hel-
sinki declaration. The study was approved by the Ethics
Committee of the Oulu University Hospital and all par-
ticipants signed an informed consent form.
Definition of major CNS complications
Eight patients were identified to have experienced major
CNS complications associated with acute NE (Table 2).
These patients suffered either pituitary haemorrhage in
their brain MRI and subsequent hormonal insufficiency
or they exhibited symptoms of significant clinical ence-
phalitis based on the criteria of Centers for Disease
Control and Prevention (CDC)[14].
Clinical data
Patients were examined as previously described in detail
[7]. Briefly, CNS symptoms were documented, cerebrosp-
inal fluid (CSF) samples were collected, brain magnetic
resonance imaging (MRI) was acquired, and electroence-
phalography (EEG) was recorded as previously described
[7]. In order to estimate the degree of tissue oedema and
the disturbance of tissue permeability, the weight change
during hospitalization, urine output during the first day
of treatment, as well as the plasma creatinine level were
recorded. Data of blood haemoglobin (Hb), thrombocyte
count, white blood cell count, serum albumin concentra-
tion, plasma C-reactive protein (CRP) concentration, CSF
protein and albumin concentrations, and CSF white cell
count were also collected. Selected patients were exam-
ined by an ophthalmologist as described earlier [15].
Patients with suspicion of pituitary injury in their MRI
were evaluted for signs of hormonal deficiencies as
described previously [7].
Virological and immunological analysis
The laboratory diagnosis of NE was based on PUUV
serology that was initially analyzed using a commercial
Table 1 Selected laboratory findings of the 8 patients experiencing major CNS complications
Patient CSF-PUUV IgM CSF-white cells CSF-protein thrombo-cytes B-white cells B-Hb P-CRP P-Creatinine
1 + 5 448 62 9,9 152 46 609
2 + 0 3265 8 20,5 184 113 353
3 na na na 28 13,3 229 115 232
4 + 5 1155 21 15,1 192 223 411
5 na 9 715 13 23,2 201 248 460
6 na na na 67 6,9 149 na 295
7 na 18 1526 8 13,8 191 131 505
8 na 2 706 11 3,9 139 169 600
The CSF PUUV IgM was determined in three patients. CSF white cell count (x10e6/l) and protein concentration (mg/l) are shown. The nadir blood thrombocyte
count (x10e9/l), blood white cell count (x10e9/l), and haemoglobin concentration (g/l) at the time of hospital entry are shown. The peak plasma CRP (mg/l) and
creatinine (μmol/l) concentrations are also provided in the table.
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(Reagena Puumala IgM EIA Kit, Reagena, Toivala, Fin-
land). In some cases, the samples were also analyzed
with an indirect immunofluorescence test for PUUV-
IgG which displayed a granular staining pattern in cases
of typical acute infection [16]. The CSF samples were
analyzed for cell count, glucose and protein concentra-
tions and CSF and serum PUUV IgM and IgG antibody
levels were titrated as described [7]. As previously
described, the CSF sample of only one patient was posi-
tive for PUUV RNA [9].
Data analysis
The patients were divided into three categories: those
without major CNS complications and negative CSF
PUUV-IgM (21 patients), patients without CNS compli-
cations and a positive for CSF PUUV-IgM finding (19
patients), and those with major CNS complications
caused by acute NE (8 patients). In addition, we
explored the clinical data of the patients positive for
CSF PUUV-IgM and elevated CSF white cell count (data
not shown in the tables). The results were analyzed with
Chi-square test, Pearson bivariate correlation test, or t-
test (PASW version 18, SPSS Inc., Chicago, IL, USA) for
statistical significance.
Results
Patients without major CNS complications
CNS-related symptoms without major CNS complications
Our first task was to analyze if the laboratory findings
differed between the patients with or without symptoms
associated with affected CNS during acute NE. We
found that all 21 patients with negative CSF PUUV IgM
as well as nearly all patients (18/19, 95%) with positive
CSF PUUV IgM complained of symptoms suggestive of
CNS involvement (headache, nausea, vertigo). Since
such a high proportion of the patients did experience
CNS-related symptoms, no statistically significant differ-
ences in age, gender, any CSF finding, or other clinical
or laboratory parameters based on these symptoms
could be detected.
CSF PUUV IgM
The CSF PUUV IgM-positive finding may be considered
to indicate intrathecal antibody production and the pos-
sibility of a true CNS infection. Based on this hypoth-
esis, we compared the properties of IgM-positive and
-negative patients. Selected clinical and laboratory find-
ings of the study patients without major CNS complica-
tions divided according to CSF PUUV IgM-negative or
-positive finding are summarized in Table 1. When
compared to those who were negative for the PUUV
IgM the patients who were positive for CSF PUUV IgM
were more often male (p < 0.05, chi-square test), their
mean plasma creatinine concentration was higher (p <
0.001, t-test), the CSF protein value elevated (p < 0.001,
t-test), and their blood white cell count was high (p <
0.001, t-test). No correlation was seen between the CSF
PUUV IgM and urine output, weight change during
hospitalization, or blood pressure values. In addition,
the severity of thrombocytopenia or the plasma CRP
concentration was not associated with the positive CSF
PUUV IgM finding. Similar results were seen in the sub-
category of patients in whom both the CSF PUUV IgM
was positive and the CSF white cell count was elevated.
Time from the onset of NE symptoms to lumbar punc-
ture did not differ between the CSF PUUV IgM positive
and negative patients.
CSF protein concentration and white cell count
It is possible that the CSF protein concentration and
white cell count can be elevated either due to a true
Table 2 Summary of the clinical properties of the 8 patients with major CNS involvement caused by acute NE
Patient gender age year clinical symptoms MRI finding hormonal status EEG
1 male 17 2009 confusion, seizures cortical
oedema
normal excessive sleepiness
2 male 47 2006 confusion, somnolence normal normal na
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diffuse delta activity and temporal periodic
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Gender, age, year of their acute NE, brief description of their illness, brain MRI, hormonal status, and EEG is given.
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sue permeability caused by the acute NE. We explored
the possibility that clinical and laboratory parameters
should possibly explain the mechanisms of the CSF find-
ings. There was a statistically significant correlation
between the CSF protein concentration and the severity
of thrombocytopenia (p < 0.05, Pearson bivariate corre-
lation test). The patients with elevated CSF protein con-
centration had a high blood white cell count (p < 0.05,
Pearson bivariate correlation test) and there was a corre-
lation between the CSF protein concentration and the
plasma creatinine level (p < 0.05, Pearson bivariate cor-
relation test). In contrast, the degree of tissue edema or
urine output displayed no association with the CSF pro-
tein concentration or white cell count. We were able to
analyze albumin concentrations from 26 CSF samples in
order to investigate possible blood-brain barrier injury.
We found that CSF albumin concentration was higher
in patients with positive PUUV IgM CSF finding com-
pared to PUUV IgM negative cases (p < 0.01, t-test).
The CSF/serum albumin ratio, however, was not differ-
ent between the CSF PUUV IgM positive and negative
cases. In addition, the CSF albumin concentrations were
similar in the CSF samples with elevated white cell
count compared to those with low CSF white cell count.
Kidney failure and tissue edema
The patients with high plasma creatinine levels also
exhibited the most significant tissue edema as demon-
strated by the correlation between with the weight
change during hospitalization and plasma creatinine
concentration (p < 0.05, Pearson bivariate correlation
test). These patients also had the lowest urine output
during the first day of treatment (p = 0.01, Pearson
bivariate correlation test). As mentioned above, the
patients with high plasma creatinine concentration had
high CSF protein concentrations (p < 0.05, Pearson
bivariate correlation test) and they also had a high blood
white cell count (p < 0.05, Pearson bivariate correlation
test).
Patients with major CNS involvement
CNS symptoms
Selected clinical, imaging, and laboratory findings of
patients with major CNS involvement are summarized
in Tables 1, 2, and 3. All patients experienced compro-
mised alertness, confusion, and somnolence at some
point during the course of their illness and two patients
developed seizures. The five patients that are summar-
ized in Table 2 developed pituitary insufficiency; two of
them recovered spontaneously but three patients contin-
ued to require hormonal replacement therapy. One
patient developed (patient 4 in Table 1 and 2) a signifi-
cant neurological condition: this male patient was
healthy and free of medication before his acute NE in
2007. During the acute illness, he suffered nausea, sig-
nificant pulmonary edema, somnolence, and impaired
awareness and he had periods of complete loss of vision.
He developed permanent pituitary insufficiency and
also, he developed a prolonged cognitive impairment
and severe neuralgia on the left side of his head. In
addition, he developed weakness of his left limbs. It
appears that his neurological condition is irreversible
and this patient has been unable to return to work.
Repeated MRI of the brain and angiography of his head
and neck have not revealed any vascular reason for his
neurological symptoms.
MRI imaging
The imaging findings of the patients with major CNS
complications caused by NE are summarized in Table 2.
Five patients had pituitary hemorrhage in their MRI and
they all developed panhypopituitarism. Three patients
(patients 2, 5, and 7, Table 2) experienced symptoms
typical of clinical encephalitis although their brain MRI
showed hemorrhage only in the pituitary.
Ophthalmological symptoms and findings in patients with
severe CNS involvement
Three male patients with major CNS findings experi-
enced a sudden, transient, and complete loss of vision
for less than 5 minutes associated with severe headache,
vomiting, and dizziness immediately before or during
their hospitalization (patients 3, 4, and 6). One patient
(patient 2) experienced a significant reduction of visual
acuity to hand movement level, light sensitivity, and
ocular pain during the first days of hospitalization.
Another patient (patient 4) suffered from intermittent
blurring of vision, diplopia, sense of defects in visual
field, and nystagmus for at least 18 months after the
acute NE. His visual field appeared normal in both
Goldmann and Humphrey 24-2 perimetry and no
abnormalities were noted in diplopia test.
A tendency towards myopia in the acute phase com-
pared to control examination was noted in the three
patients (patients 2 - 4 in Table 2) with major CNS
findings (mean refraction change 0.7 D between acute
and control examination). A major decline in intraocular
pressure (IOP; mean change 6.8 mmHg, from 15.0
mmHg to 8.1 mmHg) was measured in the two patients
(patients 3 and 4) with a pituitary injury in the acute
phase of NE compared to the control examination.
Interestingly, in one of these patients (patient 4) with
the pituitary injury, the IOP has remained at a signifi-
cantly lower level compared to that documented during
his previous ophthalmic evaluations even after the clini-
cal recovery. No change in anterior chamber depth was
noted in these patients. Compared to the control exami-
nation, the acute-phase mean 0.9 mm deepening of the
crystalline lens was noted in the three patients with
major CNS findings (from mean 5.0 mm to mean 4.1
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tion, the length of the vitreous cavity was shallower in
the patients with CNS findings (mean difference 0.5
mm, p < 0.01) than in the other patients with acute NE
(mean difference 0.2 mm). In addition, axial length of
the eye was greater in patients with CNS findings in the
acute phase compared to the control examination (mean
difference 0.35 mm).
Discussion
Our patient population and previous case reports
strongly suggests that acute NE may indeed cause severe
CNS complications [5-8,12,13]. The clinical presentation
of many of our patients included typical symptoms of
viral encephalitis and several patients developed serious
CNS-related complications. It seems understandable
that PUUV hantavirus should be considered as a possi-
ble causative viral agent in patients with encephalitis, at
least in endemic regions. Due to the expanding nature
of the NE epidemic and increasing international tour-
ism, the possibility of this clinical condition should also
be borne in mind elsewhere. It should be appreciated,
however, that the patient population of this study repre-
sents the most severely affected cases; majority of NE
patients do not require hospitalization and many of
them should recover without complications.
The presence of PUUV in the CNS during the acute
infection has been demonstrated [8,9]. It is possible that
the virus is present in the CNS early during the course
of the illness only which may explain the low number of
PUUV RNA-positive CSF findings in the previous stu-
dies [4,7]. The positive CSF PUUV IgM may be consid-
ered to indicate intrathecal antibody production and the
finding may be a reflection of a true CNS infection [7].
The severe cases in this current report demonstrate that
the acute NE may truly damage the brain and the CNS-
related symptoms during the acute NE should not sim-
ply be attributable to a transient increase in the tissue
permeability. This speculation is supported by the find-
ing that the degree of tissue edema, amount of urine
output, or blood pressure level displayed no association
with the PUUV IgM-positive CSF findings.
It is generally believed that most patients recover from
acute NE without suffering any long-term consequences
[1]. Our current report, however, suggests that some
patients may actually experience long-lasting CNS
impairment. One patient in our current study developed
a disabling neurological condition and permanent hor-
monal insufficiency following acute NE. In addition, he
suffered from intermittent blurring of vision, diplopia, a
sense of defects in visual field, and nystagmus for at
least 18 months after the acute NE. His visual field
appeared normal in both Goldmann and Humphrey 24-
2 perimetry and no abnormalities were noted in a diplo-
pia test. In addition, the IOP level of this patient
remained at a low level even after clinical recovery com-
pared to the value documented in his previous ophthal-
mic evaluations before the infection. We believe that
this may be a consequence of a permanent injury to the
ciliary body which occurred during the inflammatory
Table 3 The table summarizes the clinical and laboratory parameters studied in the NE patients categorized according
to their major CNS complications and CSF PUUV IgM findings
No major CNS complications
(n = 21)
No major CNS complications
(n = 19)
Patients with major CNS complications
(n = 8)
CSF PUUV IgM negative positive
Female (%) 47.6 15.8* 12.5*
Age (years) 52.9 45.7 38.5*
CSF white cells (x10e6/l) 1.5 4.7 6.5**
CSF protein (mg/l) 387 780** 1302***
B-thrombocytes (x10e9/l) 80 62 27**
B-white cells (x10e9/l) 7.4 11.3** 13.3**
B-Hb (g/l) 149 152 179**
P-CRP (mg/l) 100 63 149*
P-Creatinine (umol/l) 113 413*** 433***
BP, systolic (mmHg) 129 129 143
hospitalization (days) 5.0 5.1 9.3***
dialysis 0 0 0
In each category, the percentage of female gender, mean age of the patients, mean CSF white cell count, and mean CSF protein concentration are given. Blood
thrombocyte count (nadir), peak plasma creatinine level, blood white cell count and haemoglobin concentration at the time of hospital entry are reported.
Systolic blood pressure (BP) at the time of hospital entry, length of hospitalization, and number of patients treated with dialysis are given. Statistical analysis is a
comparion between the CSF PUUV IgM negative and positive cases, and the CSF PUUV IgM negative cases and the patients with major CNS complications. *
indicates p < 0.05, ** p < 0.01, and *** p < 0.001.
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these permanent injuries are in agreement with previous
studies; these studies concluded that pituitary insuffi-
ciency after an acute hantavirus infection may be more
common than formerly believed [17,18]. Mechanism of
the injury, however, remains unclear. It has been specu-
lated that the pituitary gland is highly vulnerable
because of its anatomical location and organization of
blood flow [8]. Possibility of thrombosis or vasculitis,
however, can not be ruled out. Furthermore, our study
failed to produce conclusive data on mechanisms and
severity of possible blood-brain barrier injury. Future
studies should be designed to answer these open
questions.
Our study shows that the CNS involvement during
acute NE is dependent on the age and the gender of the
patient. Most patients with a serious CNS injury or
intrathecal PUUV antibody production were male and,
in addition, the patients with major events were younger
than those exhibiting no signs of CNS involvement. Our
previous study showed lower number of abnormal CSF
findings in the patients positive for DR15(2)-DQ6 haplo-
type [7]. In that population, 86% of the patients with the
protective haplotype were male and their mean age was
48 years. These results indicate that our current obser-
vation of the young age and the male gender in adult
population is not attributable to this protective HLA
haplotype. It must be recognized, however, that serious
complications caused by NE are rarely seen in children
[19,20]. It is possible that testosterone levels may contri-
bute to the severity of the hantavirus infection [21].
Our current report demonstrates that the brain MRI
and hormonal studies should be considered at least
whenever severe NE is diagnosed in a young male
patient. It should be appreciated that the illness may
lead to long term neurological and ophthalmological
impairments which may be caused by a true CNS infec-
tion. At present, little is known about the biological
mechanisms leading to injury and further studies should
be conducted.
Conclusion
Acute PUUV hantavirus infection can cause permanent
CNS and ocular damage. In our patient population the
CNS injury was observed in young adult male patients.
It seems possible that these symptoms are attributable
to true infection of the CNS rather than increased tissue
permeability.
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